chr6-156778909-G-GAGGAGC

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_001374828.1(ARID1B):​c.1241_1246dupCAGGAG​(p.Ala414_Gly415dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000391 in 1,352,964 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00052 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00037 ( 0 hom. )

Consequence

ARID1B
NM_001374828.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.50

Publications

0 publications found
Variant links:
Genes affected
ARID1B (HGNC:18040): (AT-rich interaction domain 1B) This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ARID1B Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina, ClinGen
  • Coffin-Siris syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001374828.1
BP6
Variant 6-156778909-G-GAGGAGC is Benign according to our data. Variant chr6-156778909-G-GAGGAGC is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 588355.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000523 (77/147142) while in subpopulation EAS AF = 0.00217 (10/4618). AF 95% confidence interval is 0.00117. There are 0 homozygotes in GnomAd4. There are 38 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAd4 at 77 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID1BNM_001374828.1 linkc.1241_1246dupCAGGAG p.Ala414_Gly415dup disruptive_inframe_insertion Exon 1 of 20 ENST00000636930.2 NP_001361757.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID1BENST00000636930.2 linkc.1241_1246dupCAGGAG p.Ala414_Gly415dup disruptive_inframe_insertion Exon 1 of 20 2 NM_001374828.1 ENSP00000490491.2

Frequencies

GnomAD3 genomes
AF:
0.000524
AC:
77
AN:
147042
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000748
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00216
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00719
Gnomad NFE
AF:
0.000436
Gnomad OTH
AF:
0.00149
GnomAD2 exomes
AF:
0.0000842
AC:
2
AN:
23744
AF XY:
0.000139
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00543
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000375
AC:
452
AN:
1205822
Hom.:
0
Cov.:
35
AF XY:
0.000338
AC XY:
199
AN XY:
588806
show subpopulations
African (AFR)
AF:
0.000421
AC:
10
AN:
23726
American (AMR)
AF:
0.000691
AC:
8
AN:
11572
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17456
East Asian (EAS)
AF:
0.00250
AC:
61
AN:
24414
South Asian (SAS)
AF:
0.000147
AC:
7
AN:
47724
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37478
Middle Eastern (MID)
AF:
0.00224
AC:
9
AN:
4010
European-Non Finnish (NFE)
AF:
0.000334
AC:
331
AN:
990586
Other (OTH)
AF:
0.000532
AC:
26
AN:
48856
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.424
Heterozygous variant carriers
0
20
41
61
82
102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000523
AC:
77
AN:
147142
Hom.:
0
Cov.:
30
AF XY:
0.000529
AC XY:
38
AN XY:
71842
show subpopulations
African (AFR)
AF:
0.000746
AC:
30
AN:
40228
American (AMR)
AF:
0.000202
AC:
3
AN:
14822
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3428
East Asian (EAS)
AF:
0.00217
AC:
10
AN:
4618
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4640
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9778
Middle Eastern (MID)
AF:
0.00763
AC:
2
AN:
262
European-Non Finnish (NFE)
AF:
0.000436
AC:
29
AN:
66444
Other (OTH)
AF:
0.00147
AC:
3
AN:
2044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 22, 2022
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARID1B: BS1, BS2 -

ARID1B-related disorder Benign:1
May 24, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Inborn genetic diseases Benign:1
Oct 04, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.5
Mutation Taster
=81/19
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747438636; hg19: chr6-157100043; API